GRIFOLS | GRF - Sales Revenues

Stock Price
10.97
Daily Change
0.01 0.05%
Monthly
0.64%
Yearly
-0.27%
Q1 Forecast
10.85

GRIFOLS reported EUR1.87B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alcon AG USD 2.7B 110M Dec/2025
Almirall EUR 547.63M 12.83M Dec/2025
Amadeus IT EUR 1.64B 10M Sep/2025
Amarin USD 49.67M 23.07M Sep/2025
argenx SE USD 1.12B 132.91M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Cie Automotive EUR 974M 13M Sep/2025
Demant DKK 6.26B 810M Dec/2025
Ence Energia y Celulosa EUR 180.9M 11.4M Sep/2025
Essilor EUR 14.47B 7.6B Dec/2025
Ferrovial EUR 2.41B 350M Jun/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Inditex EUR 9.81B 269M Sep/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025
UCB EUR 3.49B 129M Jun/2025
Viscofan EUR 318.1M 6.1M Sep/2025